Cure Research for Lung cancer

Medications currently used in research into the prevention of Lung cancer:

Note:You must always seek professional medical advice about any treatment or change in treatment plans.

Some of the different medications being used in the research into prevention of Lung cancer include:

• Aspirin - relevant for women
• Acetylsalicylic acid - relevant for women
• ASA - relevant for women
• Added Strength Analgesic Pain Reliever - relevant for women
• Adult Strength Pain Reliever - relevant for women
• Aggrenox - relevant for women
• Alka-Seltzer Effervescent Pain Reliever and Antacid - relevant for women
• Alka-Seltzer Night Time - relevant for women
• Alka-Seltzer Plus - relevant for women
• Alka-Seltzer Plus Cold - relevant for women
• Anacin - relevant for women
• Anacin Maximum Strength - relevant for women
• Anacin w/Codeine - relevant for women
• Ancasal - relevant for women
• APC - relevant for women
• APC w/Codeine - relevant for women
• APO-ASA - relevant for women
• Arthritis Pain Formula - relevant for women
• Arthritis Strength Bufferin - relevant for women
• A.S.A. Enseals - relevant for women
• Asasantine - relevant for women
• Ascriptin - relevant for women
• Ascriptin A/D - relevant for women
• Aspergum - relevant for women
• Aspirin PROTECT - relevant for women
• Asprimox - relevant for women
• Astrin - relevant for women
• Axotal - relevant for women
• Azdone - relevant for women
• Bayer Aspirin - relevant for women
• Bayer Children's Chewable Aspirin - relevant for women
• Bayer Enteric Aspirin - relevant for women
• Bayer Plus - relevant for women
• BC Powder - relevant for women
• Buffaprin - relevant for women
• Bufferin - relevant for women
• Bufferin Arthritis Strength - relevant for women
• Bufferin Extra Strength - relevant for women
• Bufferin w/Codeine - relevant for women
• Cama Arthritis Pain Reliever - relevant for women
• Cardioprin - relevant for women
• Carisoprodol Compound - relevant for women
• Cope - relevant for women
• Coricidin - relevant for women
• Coryphen - relevant for women
• Coryphen-Codeine - relevant for women
• C2 Buffered - relevant for women
• Darvon Compound - relevant for women
• Dorect Fpr,I;aru As[orom - relevant for women
• Dristan - relevant for women
• Easprin - relevant for women
• Ecotrin - relevant for women
• 8-Hour Bayer - relevant for women
• Empirin - relevant for women
• Empirin w/Codeine No. 2,4 - relevant for women
• Entrophen - relevant for women
• Excedrin - relevant for women
• Excedrin Extra Strength Geltabs - relevant for women
• Excedrin Migraine - relevant for women
• Fiorinal - relevant for women
• Firoinal-C - relevant for women
• Firoinal w/Codeine - relevant for women
• Genacote - relevant for women
• Genprin - relevant for women
• Goody's Headache Powder - relevant for women
• Halprin - relevant for women
• Hepto - relevant for women
• Lortab ASA - relevant for women
• Low Dose Adult Chewable Aspirin - relevant for women
• Marnal - relevant for women
• Maximum Bayer Aspirin - relevant for women
• Measurin - relevant for women
• Midol Caplets - relevant for women
• Momentum - relevant for women
• Norgesic - relevant for women
• Norgesic Forte - relevant for women
• Norwich Aspirin - relevant for women
• Mpvasem - relevant for women
• Orphenadrine - relevant for women
• PAP w/Codeine - relevant for women
• Percodan - relevant for women
• Percodan-Demi - relevant for women
• Phenaphen - relevant for women
• Phenaphen No. 2, 3, 4 - relevant for women
• Propoxyphene Compound - relevant for women
• Riphen-10 - relevant for women
• Robaxisal - relevant for women
• Robaxisal-C - relevant for women
• Roxiprin - relevant for women
• 692 - relevant for women
• SK-65 Compound - relevant for women
• Soma Compound - relevant for women
• St. Joseph Children's Aspirin - relevant for women
• Supasa - relevant for women
• Synalgos - relevant for women
• Synalgos-DC Tablet - relevant for women
• Triaphen-10 - relevant for women
• 217 - relevant for women
• 217 Strong - relevant for women
• 292 - relevant for women
• Vanquish - relevant for women
• Verin - relevant for women
• Wesprin - relevant for women
• Zorprin - relevant for women
• Direct Formulary Aspirin - relevant for women
• Halfprin - relevant for women
• Novasen - relevant for women

Curable Types of Lung cancer

Possibly curable or rare types of Lung cancer include:

• Non- small cell lung cancer
• Adenocarcinoma of lung
• Squamous cell carcinoma
• Large cell carcinoma
• more curable types...»

Rare Types of Lung cancer:

Some rare types of Lung cancer include:

• Non- small cell lung cancer
• Adenocarcinoma of lung
• Squamous cell carcinoma
• Large cell carcinoma
• Pancoast's tumour
• more rare types...»

Latest Treatments for Lung cancer

Some of the more recent treatments for Lung cancer include:

• Surgical resection
• Chemotherapy
• Radiation therapy
• more treatments...»

Treatments for Lung cancer

Treatments to consider for Lung cancer may include:

• Surgery
  • Lung segmental resection - also called a "wedge resection"
  • Lobectomy - remove an entire lobe of a lung
  • Pneumonectomy (lung removal)
  • Cryosurgery
• Chemotherapy
• Radiation therapy
• more treatments...»

Cure Research discussion for Lung cancer:

A large-scale study, known as the PLCO (Prostate, Lung, Colorectal, and Ovarian) Cancer Screening Trial, is currently evaluating the usefulness of a blood test for the tumor marker known as CA-125 and a test called transvaginal ultrasound for ovarian cancer screening. (Source: excerpt from What You Need To Know About Ovarian Cancer: NCI)

Medical research for Lung cancer: medical news summaries:

The following medical news items are relevant to medical research for Lung cancer:

• Cancer deaths take over deaths caused by heart disease
• Cancer detected on breath by dogs
• Cancer screening tests have a high rate of false positive results
• Certain form of Vitamin E has anticancer properties
• Chemical signals involved in cancer causes found
• Chronic bronchitis and emphysema linked to lung cancer
• Colorectal cancer risk reduced in women through calcium consumption
• Cranberries may be the key to preventing and curing breast cancers
• Curry ingredient may be effective against cancer
• Drug company obtains orphan status for its new cancer drug
• Drug company stops marketing plans for new lung cancer drug due to poor trial results
• Ethnicity, socio-economic status and education all affect the risk of death from cancer
• Lung cancer may be an inheritable conditon
• New drug proving effective in reducing cancer cells following chemotherapy
• Non-alcoholic beer may inhibit cancer
• Passive smoking during childhood increases risk of adult lung cancer
• Pesticides may cause lung cancer
• Red wine reduces lung cancer risk
• Researchers aim to develop a blood test to determine presence of cancer
• Secret to lung cancer development revealed
• Selenium may have preventative benefits against certain cancers
• Smelling machine to detect lung cancer
• Traditional herbal remedies being studied provide positive results
• Two new drugs approved by FDA
• Women too are at risk of lung cancer
• More news »

Clinical Trials for Lung cancer

Some of the clinical trials for Lung cancer include:

• Differentiation of Malig. & Ben. Solitary Pulm. Nodules & Prediction of Clin. Outcome Using Perfus. Analysis of DCEMRI - This study is currently recruiting patients (Current: 23 Nov 2006)
• Yoga-Based Cancer Rehabilitation Program - This study is currently recruiting patients (Current: 23 Nov 2006)
• Phase I/II Study of Fractionated Stereotactic Radiotherapy for Medically Inoperable NSCLC or Metastatic Lung Tumours - This study is not yet open for patient recruitment (Current: 23 Nov 2006)
• The Utility of FDG-PET for Radiation Treatment in NSCLC - This study is currently recruiting patients (Current: 23 Nov 2006)
• Phase II Trial of a 96-Hour Continuous Infusion of Paclitaxel Followed by Cisplatin for Patients With Stage III/IV and Relapsed NSCLC - This study has been completed (Current: 23 Nov 2006)
• more trials...»

Evidence Based Medicine Research for Lung cancer

Medical research papers related to Lung cancer include:

• Pemetrexed (Alimta) - In combination with cisplatin for the first line treatment of patients with locally advanced or metastatic non-small cell lung cancer (NSCLC)
• Postoperative radiotherapy for non-small cell lung cancer
• Screening for lung cancer
• Pemetrexed (Alimta) - monotherapy for second line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology
• Palliative endobronchial brachytherapy for non-small cell lung cancer
• BIBW 2992 Non small cell lung cancer advanced or metastatic
• Endoscopic ultrasound and fine needle aspiration for lung cancer
• Erlotinib for the treatment of non-small cell lung cancer
• Pemetrexed (Alimta) - As a monotherapy for treatment of patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) after prior chemotherapy
• Platinum versus non-platinum chemotherapy regimens for small cell lung cancer
• Picoplatin (AMD-473) Small cell lung cancer second line
• Lung cancer (non-small-cell) - bevacizumab (terminated appraisal)
• Pemetrexed (Alimta) - Non-small cell lung cancer - maintenance therapy after first-line induction chemotherapy
• Lungscreen Lung cancer detection in high-risk patients
• Lung cancer - screening
• Bronchial intraepithelial neoplasia/early central airways lung cancer: ACCP evidence-based clinical practice guidelines. (2nd Edition)
• The noninvasive staging of non-small cell lung cancer: ACCP evidenced-based clinical practice guidelines. (2nd Edition)
• Lung cancer (Localised disease) - Radiotherapy for NSCLC
• Invasive mediastinal staging of lung cancer: ACCP evidence-based clinical practice guidelines. (2nd Edition)
• Follow-up and surveillance of the lung cancer patient following curative-intent therapy: ACCP evidence-based clinical practice guideline. (2nd Edition)
• Lung cancer
• Effect of amifostine on response rates in locally advanced non-small-cell lung cancer patients treated on randomized controlled trials: a meta-analysis
• Lung cancer (Advanced disease) - Biological agents for NSCLC
• Management of small cell lung cancer: ACCP evidence-based clinical practice guidelines. (2nd Edition)
• Palliative care in lung cancer: ACCP evidence-based clinical practice guidelines. (2nd Edition)
• Lung cancer (Localised disease) - Chemotherapy (adjuvant/neoadjuvant) for NSCLC
• Diagnostic surgical pathology in lung cancer: ACCP evidence-based clinical practice guidelines. (2nd Edition)
• Bevacizumab (Avastin) - non-small cell lung cancer
• Chemotherapy and surgery versus surgery alone in non-small cell lung cancer
• Lung cancer (Diagnosis and staging) - Sampling of the mediastinal lymph nodes using ultrasound

Click here to find more evidence-based articles on the TRIP Database

Search Specialists by State and City